Author

Lihui Zhu

Observed names: L. Zhu, LI-HUI ZHU, Li-Hui Zhu

Institutions: Gansu Provincial Hospital, Ningxia Medical University

Observed institutions: Central South University, Gansu Provincial Hospital, Hunan Cancer Hospital, Ningxia Medical University, University of South China

ORCID: 0000-0002-2390-0197

Observed ORCID: 0000-0002-2390-0197

OpenAlex ID: A5005514522

miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression

2014 · JUAN XIE, MING CHEN, et al. · Oncology Reports · 84

Rehabilitation Nursing Intervention Can Improve Dysphagia and Quality of Life of Patients Undergoing Radiotherapy for Esophageal Cancer

2021 · Xiange Zeng, Ling Li, et al. · Journal of Oncology · 16

Combining systemic inflammatory response index and albumin fibrinogen ratio to predict early serious complications and prognosis after resectable gastric cancer

2024 · Jing-Yao Ren, Da Wang, et al. · World Journal of Gastrointestinal Oncology · 13

Upregulated RACK1 attenuates gastric cancer cell growth and epithelial–mesenchymal transition via suppressing Wnt/β-catenin signaling

2019 · Lihui Zhu, Wen Chen, et al. · OncoTargets and Therapy · 10

Perioperative change trajectories and predictors of swallowing function and swallowing-related quality of life in patients with oral cancer: a longitudinal observational study

2023 · Meijun Ou, Lihui Zhu, et al. · BMJ Open · 7

Splenectomy versus splenic preservation in total gastrectomy for gastric cancer: a systematic review and meta-analysis comparing survival benefits and short-term complications

2024 · Da Wang, Jingyao Ren, et al. · Postgraduate Medicine · 3

Capecitabine for treatment of patients with advanced gastric cancer: Curative efficacy and effect on serum levels of MMP-2 and MMP-9

2015 · Yan-Ping Liu, Guo-Qing Li, et al. · World Chinese Journal of Digestology · 1

Measurement of baseline serum SDF-1 levels as a predictive biomarker for outcomes in the NCIC CTG MA.14 trial of octreotide, a somatostatin analogue in postmenopausal breast cancer.

2011 · A. Aguilar-Mahecha, M. Basik, et al. · Journal of Clinical Oncology · 1

A Pan-Cancer Analysis Indicates the Prognostic Significance and Immunological Function of V-Set Domain Containing T-Cell Activation Inhibitor 1

2023 · Jingyao Yu, Yong feng, et al. · Indian Journal of Pharmaceutical Sciences

A study on the effects of PPARγ ligand rosiglitazone in the growth of MGC803 cells transplanted into subrenal-capsule of mice

2008 · Lihui Zhu, Li Zhang, et al. · 肿瘤研究与临床

Works count: 10

Citation count: 135

H-index: 5

I10-index: 4